- Home
- MRVI vs LPAA Comparison
MRVI vs LPAA Comparison
Compare MRVI & LPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- LPAA
- Stock Information
- Founded
- MRVI 2014
- LPAA 2024
- Country
- MRVI United States
- LPAA United States
- Employees
- MRVI N/A
- LPAA N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- LPAA
- Sector
- MRVI Health Care
- LPAA
- Exchange
- MRVI Nasdaq
- LPAA Nasdaq
- Market Cap
- MRVI 371.8M
- LPAA 299.3M
- IPO Year
- MRVI 2020
- LPAA 2024
- Fundamental
- Price
- MRVI $2.42
- LPAA $10.48
- Analyst Decision
- MRVI Hold
- LPAA
- Analyst Count
- MRVI 10
- LPAA 0
- Target Price
- MRVI $5.84
- LPAA N/A
- AVG Volume (30 Days)
- MRVI 1.5M
- LPAA 12.8K
- Earning Date
- MRVI 08-11-2025
- LPAA 01-01-0001
- Dividend Yield
- MRVI N/A
- LPAA N/A
- EPS Growth
- MRVI N/A
- LPAA N/A
- EPS
- MRVI N/A
- LPAA 0.35
- Revenue
- MRVI $219,830,000.00
- LPAA N/A
- Revenue This Year
- MRVI N/A
- LPAA N/A
- Revenue Next Year
- MRVI $7.23
- LPAA N/A
- P/E Ratio
- MRVI N/A
- LPAA $29.76
- Revenue Growth
- MRVI N/A
- LPAA N/A
- 52 Week Low
- MRVI $1.67
- LPAA $9.66
- 52 Week High
- MRVI $9.60
- LPAA $10.70
- Technical
- Relative Strength Index (RSI)
- MRVI 49.60
- LPAA 70.12
- Support Level
- MRVI $2.28
- LPAA $10.43
- Resistance Level
- MRVI $2.47
- LPAA $10.45
- Average True Range (ATR)
- MRVI 0.14
- LPAA 0.01
- MACD
- MRVI -0.01
- LPAA 0.00
- Stochastic Oscillator
- MRVI 27.45
- LPAA 100.00
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About LPAA Launch One Acquisition Corp. Class A Ordinary shares
Launch One Acquisition Corp is a blank check company.